Old Web
English
Sign In
Acemap
>
Paper
>
PCN256 Health Technology Assessment for Chimeric Antigen Receptor (CAR) T-CELL Therapies for Cancer in Europe, US, and Canada
PCN256 Health Technology Assessment for Chimeric Antigen Receptor (CAR) T-CELL Therapies for Cancer in Europe, US, and Canada
2020
C. Stothard
A. Brown
S. Ralston
A Curry
D Cork
G. Hollier-Hann
Keywords:
Chimeric antigen receptor
car t cells
Cancer
Cancer research
Medicine
Health technology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]